Further mechanisms of tumor suppression by TZDs may involve the inhibition of important target genes, such as the vascular endothelial growth factor, VEGF, gene (Yang et al., 2005), the PGE2 receptor gene (Lebovic et al., 2013), and the insulin receptor gene (Costa et al., 2008). Here, INSR is linked to neoplasm.